+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Intravenous Set Market Size, Share & Trends Analysis 2024-2030 MedCore Includes: Pump Sets, Secondary Sets, and 2 more

  • PDF Icon

    Report

  • 73 Pages
  • September 2023
  • Region: Global
  • iData Research
  • ID: 5878627
In 2023, the worldwide market for intravenous (IV) sets exhibited robust growth, with a total valuation of $6.0 billion, marking a substantial 5.1% increase from the previous year when it stood at $5.7 billion. Projections indicate continued growth momentum throughout the forecast period, with a compound annual growth rate (CAGR) of 4.1%, ultimately reaching an estimated value of $7.9 billion. Notably, the current landscape of the global intravenous set market is predominantly influenced by the presence of two major players, namely Becton Dickinson (BD) and B. Braun.

Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 intravenous set companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global market for intravenous sets encompasses a range of categories, including pump sets, secondary sets, gravity sets, and extension sets.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2030, and Historical Data to 2020
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions

COVID-19 Impact

  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL INTRAVENOUS SET MARKET INSIGHTS

Within the ever-evolving realm of surgical procedures and trauma cases, there is a notable upswing in the demand for intravenous (IV) sets. Whether within the bustling confines of hospital operating rooms or in more mobile ambulatory settings, IV therapy assumes a pivotal role as a lifeline for the controlled administration of fluids and medications with precision. Moreover, in instances of emergent medical scenarios, critical care situations, and traumatic injuries, the immediate and dependable access to veins becomes paramount for the purpose of resuscitation and stabilization. It is within these intense and time-sensitive moments that the requirement for IV sets experiences a significant surge, driven by the indispensable need for consistent vascular access.

GLOBAL INTRAVENOUS SET MARKET SHARE INSIGHTS

In the year 2023, Becton Dickinson (BD) emerged as the foremost leader in the global IV set market. BD's entrenched position in various other facets of infusion therapy and related treatment markets over the years played a pivotal role in elevating it to this top-tier status. BD's distinctive advantage lies in its ability to bundle IV sets with a range of complementary products, a strategy that bestows significant benefits upon the company. This approach occasionally empowers BD to offer IV sets in substantial quantities and at a per-set cost that smaller competitors find challenging to match.

Claiming the second position in the global IV set market for 2023 was B. Braun. The company exhibited a robust presence in the pump set market, driven by its dominant role in the realm of large-volume infusion pumps. B. Braun held a significant market share in IV sets, particularly in key Western European markets such as Germany and Italy. Beyond Western Europe, the company maintained noteworthy, albeit somewhat smaller, shares in other regions.

The remaining segment of the IV set market remained fragmented, featuring a diverse array of competitors. The relatively modest manufacturing costs associated with IV sets make this sector an attractive space for smaller players to enter. Furthermore, the majority of companies engaged in the production and distribution of infusion pumps also complement their capital products with infusion sets, thereby contributing to the diversity of offerings within the market.

MARKET SEGMENTATION SUMMARY

  • Pump Set Market - Segmented By:
  • Care Setting: Hospital, Non-Hospital
  • Gravity Set Market - Segmented By:
  • Hospital, Non-Hospital
  • Secondary Set Market - Segmented By:
  • Care Setting: Hospital, Non-Hospital
  • Extension Set Market - Segmented By:
  • Care Setting: Hospital

Table of Contents

  • Executive Summary
  • Global Intravenous Set Market Overview
  • Competitive Analysis
  • Markets Included
  • Regions Included
  • Introduction
  • Market Overview
  • By Segment
  • By Region
  • Market Analysis and Forecast
  • Total Intravenous Set Market
  • Pump Set Market
  • Hospital Pump Set Market
  • Non-Hospital Pump Set Market
  • Gravity Set Market
  • Hospital Gravity Set Market
  • Non-Hospital Gravity Set Market
  • Secondary Set Market
  • Hospital Secondary Set Market
  • Non-Hospital Secondary Set Market
  • Extension Set Market
  • Hospital Extension Set Market
  • Non-Hospital Extension Set Market
  • Drivers and Limiters
  • Market Drivers
  • Market Limiters
  • Competitive Market Share Analysis

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Becton Dickinson
  • B. Braun
  • Baxter
  • ICU Medical
  • Shandong Weigao
  • Fresenius Kabi
  • Terumo
  • CODAN